[HTML][HTML] Diabetes, obesity, metabolism, and SARS-CoV-2 infection: the end of the beginning
DJ Drucker - Cell metabolism, 2021 - cell.com
The increased prevalence of obesity, diabetes, and cardiovascular risk factors in people
hospitalized with severe COVID-19 illness has engendered considerable interest in the …
hospitalized with severe COVID-19 illness has engendered considerable interest in the …
[HTML][HTML] Diabetes is most important cause for mortality in COVID-19 hospitalized patients: Systematic review and meta-analysis
The presence of SARS-CoV-2 was officially documented in Europe at the end of February
2020. Despite many observations, the real impact of COVID-19 in the European Union (EU) …
2020. Despite many observations, the real impact of COVID-19 in the European Union (EU) …
Diabetes, hypertension, body mass index, smoking and COVID-19-related mortality: a systematic review and meta-analysis of observational studies
Objectives We conducted a systematic literature review and meta-analysis of observational
studies to investigate the association between diabetes, hypertension, body mass index …
studies to investigate the association between diabetes, hypertension, body mass index …
COVID-19 and diabetes
AK Singh, K Khunti - Annual review of medicine, 2022 - annualreviews.org
The prevalence of diabetes in people with coronavirus disease 2019 (COVID-19), caused by
severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has varied worldwide …
severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has varied worldwide …
Impact of diabetes on COVID‐19 mortality and hospital outcomes from a global perspective: An umbrella systematic review and meta‐analysis
Introduction To date, COVID‐19 has claimed 4.9 million lives. Diabetes has been identified
as an independent risk factor of serious outcomes in people with COVID‐19 infection …
as an independent risk factor of serious outcomes in people with COVID‐19 infection …
Diabetes and COVID-19: The past, the present, and the future
Diabetes, one of the most prevalent chronic diseases in the world, is strongly associated
with a poor prognosis in COVID-19. Scrupulous blood sugar management is crucial, since …
with a poor prognosis in COVID-19. Scrupulous blood sugar management is crucial, since …
Preadmission use of antidiabetic medications and mortality among patients with COVID-19 having type 2 diabetes: A meta-analysis
Background Diabetes is an independent predictor of poor outcomes in patients with COVID-
19. We compared the effects of the preadmission use of antidiabetic medications on the in …
19. We compared the effects of the preadmission use of antidiabetic medications on the in …
[HTML][HTML] COVID-19 in relation to hyperglycemia and diabetes mellitus
Coronavirus disease 2019 (COVID-19), triggered by the severe acute respiratory syndrome-
coronavirus 2 (SARS-CoV-2), may lead to extrapulmonary manifestations like diabetes …
coronavirus 2 (SARS-CoV-2), may lead to extrapulmonary manifestations like diabetes …
[HTML][HTML] Diabetes and COVID-19; a bidirectional interplay
P Kazakou, V Lambadiari, I Ikonomidis… - Frontiers in …, 2022 - frontiersin.org
There seems to be a bidirectional interplay between Diabetes mellitus (DM) and coronavirus
disease 2019 (COVID-19). On the one hand, people with diabetes are at higher risk of fatal …
disease 2019 (COVID-19). On the one hand, people with diabetes are at higher risk of fatal …
Association between glucagon-like peptide 1 receptor agonist and sodium–glucose cotransporter 2 inhibitor use and COVID-19 outcomes
OBJECTIVE To determine the respective associations of premorbid glucagon-like peptide-1
receptor agonist (GLP1-RA) and sodium–glucose cotransporter 2 inhibitor (SGLT2i) use …
receptor agonist (GLP1-RA) and sodium–glucose cotransporter 2 inhibitor (SGLT2i) use …